Breaking new ground in heart failure management: novel therapies and future frontiers
Heart failure (HF) management is advancing in the field of cardiology, driven by the increasing availability of progressive medications. Emerging pharmacological therapies in heart failure management include SGLT-2 inhibitors, ARNI, Vericiguat, and Omecamtiv. Other novel therapies that are changing...
Saved in:
| Main Authors: | Arbab Khalid, Paulette Rodriguez, Vasiliki Tasouli-Drakou, Abu-Bakr Ahmed, Spencer Thatcher, Jasmine K. Dugal, Aditi Singh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1643971/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
by: Elina Khattab, et al.
Published: (2025-01-01) -
Breaking new ground in pulmonary fibrosis: Targeting Pathways and Therapeutic Innovations
by: Swadip Mishra
Published: (2025-04-01) -
Updates on New Therapies for Patients with CKD
by: Tushar Tarun, et al.
Published: (2024-01-01) -
A Narrative Review of Current and Investigational Therapies in Hypertrophic Cardiomyopathy
by: Ian Ogurek, et al.
Published: (2025-05-01) -
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Connective Tissue Disease Associated Interstitial Lung Disease
by: Ju Hyun Oh, et al.
Published: (2025-04-01)